230 related articles for article (PubMed ID: 3902296)
1. Antinuclear antibodies in progressive systemic sclerosis.
Riboldi P; Asero R; Origgi L; Crespi S; Meroni PL; Sguotti C; Sabbadini MG
Clin Exp Rheumatol; 1985; 3(3):205-11. PubMed ID: 3902296
[TBL] [Abstract][Full Text] [Related]
2. Scl 70 antibody--a specific marker of systemic sclerosis.
Jarzabek-Chorzelska M; Blaszczyk M; Jablonska S; Chorzelski T; Kumar V; Beutner EH
Br J Dermatol; 1986 Oct; 115(4):393-401. PubMed ID: 3535866
[TBL] [Abstract][Full Text] [Related]
3. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.
Tan EM; Rodnan GP; Garcia I; Moroi Y; Fritzler MJ; Peebles C
Arthritis Rheum; 1980 Jun; 23(6):617-25. PubMed ID: 6155920
[TBL] [Abstract][Full Text] [Related]
4. Serological markers in progressive systemic sclerosis: clinical correlations.
Catoggio LJ; Bernstein RM; Black CM; Hughes GR; Maddison PJ
Ann Rheum Dis; 1983 Feb; 42(1):23-7. PubMed ID: 6402991
[TBL] [Abstract][Full Text] [Related]
5. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
[TBL] [Abstract][Full Text] [Related]
6. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis.
Bernstein RM; Steigerwald JC; Tan EM
Clin Exp Immunol; 1982 Apr; 48(1):43-51. PubMed ID: 7044633
[TBL] [Abstract][Full Text] [Related]
7. [Anti-Scl-70 antibodies in systemic scleroderma].
Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
[TBL] [Abstract][Full Text] [Related]
8. [Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance].
Meurer M; Scharf A; Luderschmidt C; Braun-Falco O
Dtsch Med Wochenschr; 1985 Jan; 110(1):8-14. PubMed ID: 3880700
[TBL] [Abstract][Full Text] [Related]
9. [Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma].
Rouquette-Gally AM; Stern MH; Prost AC; Abuaf N; Homberg JC; Combrisson A
Presse Med; 1985 Jul 13-20; 14(28):1497-500. PubMed ID: 2931679
[TBL] [Abstract][Full Text] [Related]
10. Clinical subsets of scleroderma: relevance of fluorescent and precipitating antinuclear antibodies.
Cassani F; Tosti A; Bianchi FB; Fusconi M; Selleri L; Baffoni L; Veronesi S; Volta U; Lenzi M; Pisi E
Clin Exp Rheumatol; 1987; 5(1):23-8. PubMed ID: 3109797
[TBL] [Abstract][Full Text] [Related]
11. Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.
Maddison PJ; Skinner RP; Pereira RS; Black CM; Ansell BM; Jayson MI; Rowell NR; Welsh KI
Ann Rheum Dis; 1986 Oct; 45(10):793-9. PubMed ID: 3098192
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of antinuclear antibodies in progressive systemic sclerosis].
Scagliusi P; De Lucia M; Di Luca ML; Pannarale M; Pipitone V
Minerva Med; 1984 Feb; 75(5):161-6. PubMed ID: 6366619
[TBL] [Abstract][Full Text] [Related]
13. Anti-Scl-70 antibodies detected by immunoblotting in progressive systemic sclerosis: specificity and clinical correlations.
Aeschlimann A; Meyer O; Bourgeois P; Haim T; Belmatoug N; Palazzo E; Kahn MF
Ann Rheum Dis; 1989 Dec; 48(12):992-7. PubMed ID: 2515813
[TBL] [Abstract][Full Text] [Related]
14. [Significance of anti-centromere antibodies. Clinical value].
Meyer O; Haim T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
[TBL] [Abstract][Full Text] [Related]
15. Antinuclear antibodies in localized scleroderma.
Takehara K; Moroi Y; Nakabayashi Y; Ishibashi Y
Arthritis Rheum; 1983 May; 26(5):612-6. PubMed ID: 6405756
[TBL] [Abstract][Full Text] [Related]
16. Antinuclear antibodies in the relatives of patients with systemic sclerosis.
Takehara K; Moroi Y; Ishibashi Y
Br J Dermatol; 1985 Jan; 112(1):23-33. PubMed ID: 3918553
[TBL] [Abstract][Full Text] [Related]
17. Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases.
Ruffatti A; Calligaro A; Ferri C; Bombardieri S; Gambari PF; Todesco S
J Clin Lab Immunol; 1985 Apr; 16(4):227-9. PubMed ID: 3874966
[TBL] [Abstract][Full Text] [Related]
18. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
Bunn CC; Denton CP; Shi-Wen X; Knight C; Black CM
Br J Rheumatol; 1998 Jan; 37(1):15-20. PubMed ID: 9487245
[TBL] [Abstract][Full Text] [Related]
19. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
[TBL] [Abstract][Full Text] [Related]
20. [Anticentromere antibodies and other antinuclear antibodies in progressive systemic sclerosis].
Rojas C; Silva MC; Pérez L; Ruiz F
Rev Med Chil; 1985 May; 113(5):409-14. PubMed ID: 3912881
[No Abstract] [Full Text] [Related]
[Next] [New Search]